Alivus Life Sciences Ltd
Microcap 250
₹1,388.80
-0.10%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Comfortable interest cover: operating profit covers interest about 6.7 times.
- Net profit margin is strong at 18.7%.
- Pays a dividend (yield about 0.36%).
- Promoters hold a majority stake (74.87%).
!Watch-points
No notable watch-points flagged by the automated checks.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₹ 17,050 Cr
Current Price₹ 1,388.80
High / Low₹ 1,493.80 / 819.00
Stock P/E28.290895
Book Value—
Dividend Yield0%
ROCE—
ROE—
Face Value₹ 2.00
Debt to Equity—
PEG Ratio1.42
EV / EBITDA27.29
Industry PE35.70
P/B Ratio5.124383
EPS₹ 358.74
Debt—
PAT Margin18.67%
Cash PAT₹ 385 Cr
ICR6.72
Promoter Holding74.87%
FII Holding5.54%
DII Holding7.18%
Public Holding12.42%
Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity